MolecuLight provides clinicians with an innovative and simple to use handheld fluorescence imaging device that makes bacteria visible during clinical wound assessment for the first time. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight has the potential to significantly […]Read More
The device provides real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques.
TORONTO, Oct. 20, 2015 /CNW/ - MolecuLight Inc. has been authorized to sell the MolecuLight i:X by Health Canada. The approval will allow the company to begin selling the product throughout Canada. MolecuLight i:X is a novel, handheld fluorescence … [Read More...]
Ontario healthcare innovator, MolecuLight Inc., is developing a hand-held optical imaging technology designed to visualize bacteria in real-time at the point-of-care. Founded by Dr. Ralph DaCosta, Scientist at The Princess Margaret Cancer Centre and … [Read More...]
MolecuLight launched the MolecuLight i:X at the CAWC (Canadian Association of Wound Care) Conference in Toronto, Canada (October 30th-November 1st 2015). Clinicians across Canada attending the CAWC benefitted from a close up view of the MolecuLight i:X imaging device during the Exhibit sessions. Recently approved by Health Canada, the MolecuLight i:X is intended to be […]Read More